SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-298762
Filing Date
2018-10-15
Accepted
2018-10-15 06:17:59
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d635729ds3.htm S-3 189057
2 EX-4.4 d635729dex44.htm EX-4.4 335357
3 EX-5.1 d635729dex51.htm EX-5.1 30526
4 EX-23.1 d635729dex231.htm EX-23.1 2872
5 GRAPHIC g635729g10t39.jpg GRAPHIC 44755
6 GRAPHIC g635729g39c41.jpg GRAPHIC 2836
7 GRAPHIC g635729g57z99.jpg GRAPHIC 5638
8 GRAPHIC g635729g89i39.jpg GRAPHIC 3912
9 GRAPHIC g635729g96n10.jpg GRAPHIC 1077
  Complete submission text file 0001193125-18-298762.txt   639702
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227818 | Film No.: 181121254
SIC: 2836 Biological Products, (No Diagnostic Substances)